HIGHLY VARIABLE SIALYLATION STATUS OF DONOR-SPECIFIC ANTIBODIES DOES NOT IMPACT HUMORAL REJECTION OUTCOMES

被引：0
|
作者：
Barba, Thomas [1 ]
Harb, Jean [2 ]
Ducreux, Stephanie [3 ]
Koenig, Alice [4 ]
Mathias, Virginie [3 ]
Rabeyrin, Maud [5 ]
Pouliquen, Eric [6 ]
Sicard, Antoine [4 ]
Chartoire, Dimitri [4 ]
Dugast, Emilie [7 ]
Defrance, Thierry [4 ]
Morelon, Emmanuel [6 ]
Brouard, Sophie [7 ]
Dubois, Valerie [3 ]
Thaunat, Olivier [4 ]
机构：
[1] Hosp Civils Lyon, INSERM, U1111, Lyon, France
[2] Nantes Univ Hosp, Biochem Lab, Nantes, France
[3] French Natl Blood Serv EFS, HLA Lab, Lyon, France
[4] French Natl Inst Hlth & Med Res INSERM, U1111, Lyon, France
[5] Hosp Civils Lyon, Dept Pathol, Bron, France
[6] Hosp Civils Lyon, Edouard Herriot Hosp, Dept Transplantat Nephrol & Clin Immunol 16, Lyon, France
[7] French Natl Inst Hlth & Med Res INSERM, UMR1064, Nantes, France
来源：
TRANSPLANT INTERNATIONAL | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
BOS361
引用
收藏
页码：236 / 236
页数：1
相关论文
共 50 条
  • [41] Impact of C1q-fixing donor-specific antibodies on pancreas transplant outcomes
    Vidigal, Ana Claudia
    Perosa, Marcelo
    Rangel, Erika B.
    TRANSPLANTATION, 2023, 107 (10) : 106 - 106
  • [42] ANTIBODY MEDIATED REJECTION IN PATIENTS WITH PERSISTENT VS PREFORMED DONOR-SPECIFIC ANTIBODIES
    Redondo Pachon, Dolores
    Jose Perez-Saez, Maria
    Mir, Marisa
    Gimeno, Javier
    Garcia, Carme
    Jose Hernandez, Juan
    Yelamos, Jose
    Pascual, Julio
    Crespo, Marta
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [43] Donor-specific antibodies and antibody-mediated rejection in vascularized composite allotransplantation
    Weissenbacher, Annemarie
    Loupy, Alexandre
    Chandraker, Anil
    Schneeberger, Stefan
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2016, 21 (05) : 510 - 515
  • [44] Impact of Transient and Persistent Donor-Specific Antibodies in Lung Transplantation
    Auner, S.
    Hillebrand, C.
    Boehm, P. M.
    Boecker, J.
    Koren, D.
    Schwarz, S.
    Kovacs, Z.
    Murakoezy, G.
    Fischer, G.
    Aigner, C.
    Hoetzenecker, K.
    Jaksch, P.
    Benazzo, A.
    TRANSPLANT INTERNATIONAL, 2024, 37
  • [45] Inferior Kidney Allograft Outcomes in Patients With De Novo Donor-Specific Antibodies Are Due to Acute Rejection Episodes
    Cooper, James E.
    Gralla, Jane
    Cagle, Linda
    Goldberg, Ryan
    Chan, Laurence
    Wiseman, Alexander C.
    TRANSPLANTATION, 2011, 91 (10) : 1103 - 1109
  • [46] How Do We Interpret the Presence of Donor-Specific Antibodies When There Is No Rejection?
    Crew, R. John
    Fajardo, Melissa
    KIDNEY INTERNATIONAL REPORTS, 2019, 4 (08): : 1040 - 1042
  • [47] Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence
    Pizzo, Helen P.
    Ettenger, Robert B.
    Gjertson, David W.
    Reed, Elaine F.
    Zhang, Jennifer
    Gritsch, H. Albin
    Tsai, Eileen W.
    PEDIATRIC NEPHROLOGY, 2016, 31 (12) : 2345 - 2352
  • [48] THE IMPACT OF DONOR-SPECIFIC ANTIBODIES ON INDUCTION THERAPY IN RENAL TRANSPLANTATION
    Patrick, Lan
    John, Saunders
    Steve, Chadban
    David, Gracey
    Kate, Wyburn
    Lorraine, Garry
    Jane, Mawson
    Josette, Eris
    IMMUNOLOGY AND CELL BIOLOGY, 2011, 89 (07): : A27 - A27
  • [49] The Impact of Rituximab On Renal Allograft Outcomes in Patients With Preformed Low Level Donor-Specific Antibodies
    Ravichandran, B.
    Manitpisitkul, W.
    Gillespie, M.
    Wilson, N.
    Ugarte, R.
    Bartlett, S.
    Haririan, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 439 - 439
  • [50] Impact of low-level pretransplant donor-specific antibodies on outcomes after kidney transplantation
    Parajuli, Sandesh
    Bath, Natalie M.
    Hidalgo, Luis
    Leverson, Glen
    Garg, Neetika
    R. Redfield, Robert, III
    Mandelbrot, Didier A.
    IMMUNITY INFLAMMATION AND DISEASE, 2021, 9 (04) : 1508 - 1519
12345